Aerobic Biotransformation and Defluorination of Fluoroalkylether Substances (ether PFAS): Substrate Specificity, Pathways, and Applications

• Published in: Environmental science & technology letters Vol. 10; no. 9; pp. 755 - 761
• Main Authors: Jin, Bosen, Zhu, Yiwen, Zhao, Weiyang, Liu, Zekun, Che, Shun, Chen, Kunpeng, Lin, Ying-Hsuan, Liu, Jinyong, Men, Yujie
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 12.09.2023
• Subjects: activated sludge; biodegradability; Bioremediation and Biotechnology; biotransformation; carboxylic acids; cost effectiveness; environmental fate; moieties; perfluorooctanoic acid; substrate specificity; technology; United States Environmental Protection Agency; GenX; PFAS treatment train; aerobic biotransformation; defluorination; ether PFAS; structural specificity
• ISSN: 2328-8930; 2328-8930
• DOI: 10.1021/acs.estlett.3c00411

Fluoroalkylether substances (ether PFAS) constitute a large group of emerging PFAS with uncertain environmental fate. Among them, GenX is the well-known alternative to perfluorooctanoic acid and one of the six proposed PFAS to be regulated by the U.S. Environmental Protection Agency. This study investigated the structure–biodegradability relationship for 12 different ether PFAS with a carboxylic acid headgroup in activated sludge communities. Only polyfluorinated ethers with at least one -CH2- moiety adjacent to or a CC bond in the proximity of the ether bond underwent active biotransformation via oxidative and hydrolytic O-dealkylation. The bioreactions at ether bonds led to the formation of unstable fluoroalcohol intermediates subject to spontaneous defluorination. We further demonstrated that this aerobic biotransformation/defluorination could complement the advanced reduction process in a treatment train system to achieve more cost-effective treatment for GenX and other recalcitrant perfluorinated ether PFAS. These findings provide essential insights into the environmental fate of ether PFAS, the design of biodegradable alternative PFAS, and the development of cost-effective ether PFAS treatment strategies.